This was confirmed in a xenograft model of thyroid cancer, whereby luteolin treatment at 50 mg/kg decreased tumor growth in vivo, and this anti-tumor effect was abolished by BANCR overexpression [64]. This evidence concerns the gene BANCR and neoplasm.